OncoCyte

About:

OncoCyte is a biotech company helping save lives and improve outcomes by accelerating and optimizing the diagnosis and treatment of cancer.

Website: http://www.oncocyte.com

Twitter/X: oncocytecorp

Top Investors: Bio-Rad Laboratories

Description:

OncoCyte is a biotechnology company that focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company's mission is to provide actionable answers to physicians and patients at critical decision points along the lung cancer care continuum, to optimize diagnosis and treatment, improve patient outcomes, and reduce the overall cost of care. OncoCyte was established in 2009 and is based in Alameda, California.

Total Funding Amount:

$83.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Irvine, California, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)oncocyte.com

Founders:

Karen Chapman

Number of Employees:

51-100

Last Funding Date:

2024-10-02

IPO Status:

Public

Industries:

© 2025 bioDAO.ai